Quantum computing company D-Wave Systems' shares show no significant change in market value.
In a recent turn of events, The Portnoy Law Firm has initiated an investigation into potential securities violations by D-Wave Quantum. This move was triggered by a critical report from Kerrisdale Capital in April 2025, which questioned the credibility of D-Wave's quantum annealing technology and labelled it as 'commercially hopeless.' The report also alleged that the hybrid solutions predominantly rely on classical computing methods.
Despite this damning critique, D-Wave's stock has experienced significant volatility. However, a rally was observed following the first 'Qubits Japan 2025' user conference in Tokyo, with the stock rising by approximately 19% yesterday and continuing its upward trend today.
The conference also saw D-Wave announcing an 83% annual booking growth in the Asia-Pacific region. In addition, the company announced new pilot projects with Japan Tobacco for quantum AI drug research and a collaboration with NTT DOCOMO that reduced mobile network congestion in tests by 15%.
The latest analysis from September 19 provides guidance on whether D-Wave Quantum shareholders should buy or sell. However, the question of whether investors should sell immediately or buy D-Wave Quantum remains unanswered.
It's worth noting that D-Wave Quantum's Q2 2025 revenue was $3.1 million, representing a 42% year-over-year increase. Yet, the company continues to incur substantial net losses due to R&D investments.
The Q3 results for D-Wave Quantum are due around November 13, 2025. Further developments in the ongoing investigation are pending.
For those seeking more information, a free analysis from September 19 offers insights on what action to take regarding D-Wave Quantum shares. As the situation unfolds, investors are advised to stay informed and make decisions based on the latest developments.
